023910 — DaehanPharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual balance sheet for DaehanPharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53,866	67,600	96,415	97,607	104,359
Net Total Accounts Receivable
Net Total Receivables	37,215	30,188	30,384	33,264	31,878
Total Inventory
Prepaid Expenses
Total Current Assets	111,130	121,684	147,539	155,886	159,905
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	125,820	113,396	113,831	113,236	125,853
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	246,852	253,090	272,542	276,980	294,252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	42,717	39,224	46,119	42,686	41,300
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	80,076	71,166	69,734	51,582	46,278
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	166,775	181,923	202,808	225,398	247,974
Total Liabilities & Shareholders' Equity	246,852	253,090	272,542	276,980	294,252
Total Common Shares Outstanding